Farther Finance Advisors, LLC Ikena Oncology, Inc. Transaction History
Farther Finance Advisors, LLC
- $3.92 Trillion
- Q1 2025
A detailed history of Farther Finance Advisors, LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 108 shares of IKNA stock, worth $127. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108
Previous 108
-0.0%
Holding current value
$127
Previous $177,000
23.73%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IKNA
# of Institutions
54Shares Held
31.8MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$5.92 Million1.36% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$4.83 Million2.87% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$4.73 Million0.25% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.59MShares$4.23 Million3.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$4.18 Million0.16% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $42.8M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...